Edition:
United States

People: Catalyst Pharmaceuticals Inc (CPRX.O)

CPRX.O on Consolidated Issue listed on NASDAQ Capital Market

1.15USD
28 Sep 2016
Change (% chg)

$-0.02 (-1.71%)
Prev Close
$1.17
Open
$1.18
Day's High
$1.19
Day's Low
$1.11
Volume
421,788
Avg. Vol
928,302
52-wk High
$3.68
52-wk Low
$0.51

McEnany, Patrick 

Mr. Patrick J. McEnany is the Chairman of the Board, President, Chief Executive Officer of Catalyst Pharmaceutical Partners, Inc. Mr. McEnany has been CEO and a director since formation in January 2002. He became Chairman and President in March 2006. From 1999 to 2002, Mr. McEnany was a consultant to the pharmaceutical industry. From 1991 to 1997, Mr. McEnany was Chairman and CEO of Royce Laboratories, Inc., a generic pharmaceutical manufacturer. From 1997 to 1998, after the merger of Royce into Watson Pharmaceuticals, Inc., Mr. McEnany served as president of the wholly-owned Royce Laboratories subsidiary and vice president of corporate development for Watson Pharmaceuticals, Inc. From 1993 to 1997, he also served as vice chairman and a director of the National Association of Pharmaceutical Manufacturers. He currently serves on the board of directors of CESCA Therapeutics Inc. (f/k/a ThermoGenesis Corp.) and the Jackson Memorial Hospital Foundation, and over the last 30 years has served as a director for numerous other public companies. The Board of Directors believes the characteristics that qualify Mr. McEnany for election to the Board include his long-term experience in the pharmaceutical industry and his business leadership experience.

Basic Compensation

Total Annual Compensation, USD 510,000
Restricted Stock Awards, USD 226,400
Long-Term Incentive Plans, USD --
All Other, USD 734,487
Fiscal Year Total, USD 1,470,890

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --